ZNF423 patient variants, truncations, and in-frame deletions in mice define an allele-dependent range of midline brain abnormalities

PLoS Genet. 2020 Sep 14;16(9):e1009017. doi: 10.1371/journal.pgen.1009017. eCollection 2020 Sep.

Abstract

Interpreting rare variants remains a challenge in personal genomics, especially for disorders with several causal genes and for genes that cause multiple disorders. ZNF423 encodes a transcriptional regulatory protein that intersects several developmental pathways. ZNF423 has been implicated in rare neurodevelopmental disorders, consistent with midline brain defects in Zfp423-mutant mice, but pathogenic potential of most patient variants remains uncertain. We engineered ~50 patient-derived and small deletion variants into the highly-conserved mouse ortholog and examined neuroanatomical measures for 791 littermate pairs. Three substitutions previously asserted pathogenic appeared benign, while a fourth was effectively null. Heterozygous premature termination codon (PTC) variants showed mild haploabnormality, consistent with loss-of-function intolerance inferred from human population data. In-frame deletions of specific zinc fingers showed mild to moderate abnormalities, as did low-expression variants. These results affirm the need for functional validation of rare variants in biological context and demonstrate cost-effective modeling of neuroanatomical abnormalities in mice.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alleles
  • Animals
  • Brain / pathology
  • Brain Diseases / genetics
  • Disease Models, Animal
  • Female
  • Gene Frequency / genetics
  • Genomics
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nervous System Malformations / genetics
  • Neural Tube Defects / genetics*
  • Neurodevelopmental Disorders / genetics
  • Proteins / genetics*
  • Proteins / metabolism
  • Transcription Factors / genetics
  • Zinc Fingers

Substances

  • Proteins
  • Transcription Factors
  • ornithine decarboxylase antizyme